Report Company Directory

Antisense Therapeutics

• Antisense Therapeutics - Breaking the mould in DMD treatment by Edison Investment Research
• Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets by GlobeNewsWire
• Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets by GlobeNewsWire
• New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2 by GlobeNewsWire
• Antisense Therapeutics to present poster at world’s largest NMD conference by GlobeNewsWire
• Phylogica Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments by MarketLine
• Ford Equity International Rating and Forecast Report by Ford Equity Research

ANTLER GOLD INC

ANTLER HILL MINING LTD

Antler Hill Oil & Gas

• Antler Hill Announces Private Placement, Consolidation and Continuation into British Columbia by Newsfile Corp.
• Antler Hill Announces Change of Management by Newsfile Corp.
• Antler Hill Enters into Definitive Agreement for Qualifying Transaction by Newsfile Corp.

Antofagasta plc

• Global/EMEA Sustainability "ESG news & views, Vol. 40, February" Kalb by UBS AG
• EMEA Sustainability "Decarb ideas list refresh" Kalb by UBS AG
• Mining Strategy "Postcards from the US/Europe" Major by UBS AG
• Global Equity Strategy "10 Surprises for 2026" Garthwaite by UBS AG
• RIO, STEEL BRAZIL, MT, VOE, STRATEGY, ANTO, AAL, LITHIUM by BNP Paribas
• On the road by BNP Paribas
• Antofagasta Plc "Downgrade to Neutral after outperformance" (Neutral) Major by UBS AG
• GREEN STEEL, STEEL EU, MINING EQUIPMENT, GLEN, ANTO, NDA by BNP Paribas
• 4Q25 production first take - good end to 2025 by BNP Paribas
• Antofagasta Plc "4Q25 production: On track" (Buy) Major by UBS AG